Tradestie Institutional Equity Comparison Engine

MYO vs NPCE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NPCE Overall Edge

NPCE Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neuropace, Inc. Common Stock (NPCE) driven by superior Valuation, Growth & Margin while MYO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, MYO trades at N/M Forward P/E with -21.8% operating margin (+22.2% YoY revenue) versus NPCE at 91.7x Forward P/E and -9.6% operating margin (-1.1% YoY). In options structure, MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro) against NPCE sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NPCE
MYO N/M vs NPCE 91.7x Fwd P/E
Growth & Margin Winner NPCE
Op Margin -21.8% vs -9.6% ยท YoY +22.2% vs -1.1%
Momentum & Technical Winner MYO
1Y +12.3% vs -43.6% ยท 52W Pos 16% vs 18%
Options & Structure Winner MYO
UNCLASSIFIED (81st %ile IV) vs BREAKDOWN (10th %ile IV)
MYO NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap $33.7M
1M Return -33.52%
1Y Return +12.3%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 43.0 Flow 58.0 Mom 59.0
NPCE NASDAQ
Neuropace, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$7.95
-2.33% 1D
Market Cap $280.4M
1M Return -39.5%
1Y Return -43.62%
Forward P/E 91.7x
Unified AI Score
54.4 / 100 HOLD
Tech 55.0 Fund 61.0 Flow 67.0 Mom 73.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MYO +12.3% NPCE -43.62% Spread: +55.92 pp (MYO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MYO Revenue NPCE Revenue MYO Op. Margin NPCE Op. Margin Margin Edge
FY2018 $0M N/A -430.8% N/A MYO
FY2019 $0M N/A -281.3% N/A MYO
FY2020 $10M $40M -138.5% -31.7% NPCE
FY2021 $10M $50M -74.1% -52.5% NPCE
FY2022 $20M $50M -68.6% -89.6% MYO
FY2023 $20M $70M -42.8% -41.5% NPCE
FY2024 $30M $80M -19.1% -27.1% MYO
FY2025 $40M $100M -35.2% -16.3% NPCE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MYO (2) vs NPCE (8)
Institutional Metric MYO NPCE Criterion Row Winner
Market Capitalization Scale $33.7M $280.4M Larger Scale NPCE
Trailing P/E Ratio Valuation N/M 91.7x Lower Multiple NPCE
Forward P/E Ratio Valuation N/M 91.7x Lower Multiple NPCE
Revenue Growth (YoY) Growth +22.2% -1.1% Higher Growth MYO
Operating Margin (TTM) Profitability -21.8% -9.6% Higher Margin NPCE
Net Profit Margin Profitability -33.1% -17.7% Higher Margin NPCE
Return on Equity (ROE) Capital Efficiency -173.5% -97.0% Higher ROE NPCE
52-Week Range Position Momentum 16% ($1โ€“$2) 18% ($5โ€“$20) Stronger Trend NPCE
Beta / 30D Volatility Risk Regime 2.22ฮฒ ยท 107% Vol 1.17ฮฒ ยท 135% Vol Lower Realized Risk MYO
Unified Institutional Score Composite Signal 40.1 / 100 (SELL) 54.4 / 100 (HOLD) Higher Composite NPCE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MYO vs NPCE Buy Guide
MYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 81st %ile
IV Regime Extreme (>80th %ile)
Live MYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NPCE BREAKDOWN
137d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live NPCE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MYO nor NPCE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.